Team

Dr. Sebastian Goy, CEO

Sebastian has worked in the field of new drug candidates, their preclinical development and translation for more than 10 years focusing on biologicals and novel vaccines.

Prof. Dr. Wolfgang Hammerschmidt, CSO

Wolfgang is an expert in the field of herpesvirus biology and immunology with a focus on EBV for more than 30 years and is one of the main inventors of the EBV-001 technology.

Dagmar Pich

Dagmar is co-inventor of the EB-VLP technology with decades of experience in all aspects of EB-VLP production.

Dr. Julia Damaschke

Julia is specialized in product-related analytics and assay development.

Advisory board

PD Dr. med Axel Polack

Axel is a senior venture capital (VC) expert and has worked in basic and translational EBV research at the start of his career.

Dr. Klaus Schwamborn

Klaus worked in vaccine and antibody development for more than 20 years and is the head of vaccine development at the DZIF.

Prof. Dr. Wolfgang Hammerschmidt

With his longstanding expertise in EBV research Wolfgang acts as CSO and board member.